Jefferies has adjusted its price target for Teladoc (TDOC, Financial), reducing it from $10 to $8, while maintaining a Hold rating on the shares. The decision follows a notable decline in first-quarter performance for BetterHelp, Teladoc's mental health service, which saw a year-over-year decrease of approximately 20%.
The analyst pointed out that expectations for Teladoc might need further moderation given the current performance trends. Additionally, there is limited visibility into the future growth strategy of the company, which contributes to the Hold rating. This suggests investors may need to exercise caution as the company navigates these challenges.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 19 analysts, the average target price for Teladoc Health Inc (TDOC, Financial) is $10.26 with a high estimate of $14.00 and a low estimate of $8.00. The average target implies an upside of 55.27% from the current price of $6.61. More detailed estimate data can be found on the Teladoc Health Inc (TDOC) Forecast page.
Based on the consensus recommendation from 26 brokerage firms, Teladoc Health Inc's (TDOC, Financial) average brokerage recommendation is currently 2.8, indicating "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Teladoc Health Inc (TDOC, Financial) in one year is $21.69, suggesting a upside of 228.14% from the current price of $6.61. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Teladoc Health Inc (TDOC) Summary page.
